D. Money, Terry Lee, C. O’Brien
Oct 1, 2019
Citations
1
Influential Citations
21
Citations
Quality indicators
Journal
BJOG: An International Journal of Obstetrics & Gynaecology
Abstract
Dolutegravir is recommended worldwide as a first‐line antiretroviral therapy (ART) for individuals living with HIV. A recent study reported increased rates of neural tube defects in infants of dolutegravir‐treated women. This study examined rates of congenital anomalies in infants born to women living with HIV (WLWH) in Canada.